Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells
- PMID: 9457313
- DOI: 10.1016/s0090-4295(97)00491-3
Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells
Abstract
Objectives: Recently, it was confirmed that angiogenesis is important in the development and spread of a variety of human cancers, including prostate cancer (PCa). Tumor neovascularization is thought to be controlled by chemical signals, known as angiogenic factors (AF). To date, little is known regarding the existence and role of AF in PCa. We previously reported on vascular endothelial growth factor (VEGF) in PCa. Currently, we compare VEGF expression with that of interleukin-8 (IL-8), another putative regulator of angiogenesis. We evaluated the expression of these two important AF in PCa and explored the role of inflammatory cytokines IL-1 and tumor necrosis factor (TNF) in their regulation.
Methods: Ex vivo studies involved previously reported immunohistochemical analysis for VEGF and recent evaluation of IL-8 expression and distribution in archival tissue samples of PCa, benign prostatic hyperplasia (BPH), and normal prostate tissue. In vitro studies used PCa cells (DU-145) grown in culture and stimulated with cytokines thought to induce VEGF and IL-8 (ie, IL-1 alpha, IL-1 beta, TNF-alpha, and TNF-beta). After 24 hours, with or without cytokines, cell culture supernatants were analyzed by enzyme-linked immunosorbent assay or radioimmunoassay for VEGF or IL-8 levels.
Results: Immunohistochemical studies of prostate tissue showed that PCa cells stained positively for VEGF and IL-8. Benign prostatic hyperplasia and normal prostate cells displayed little staining for either AF. Low levels of VEGF and IL-8 were produced by unstimulated DU-145 cells. Induction of DU-145 cells with cytokines resulted in differential stimulation whereby TNF was the predominant inducer of VEGF, whereas IL-1 was the predominant inducer of IL-8.
Conclusions: Our results indicate that significant levels of VEGF and IL-8 are present in PCa, but not BPH or normal prostate cells in vivo. In vitro studies suggest that differential regulation of AF expression occurs in PCa. Because IL-1 and TNF are present in the PCa tumor microenvironment, it is likely that differential regulation of AF also occurs in human PCa and contributes to differential tumor growth and metastasis.
Similar articles
-
Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells.J Urol. 1997 Jun;157(6):2329-33. J Urol. 1997. PMID: 9146665
-
Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients.Prostate. 2000 Sep 15;45(1):72-9. doi: 10.1002/1097-0045(20000915)45:1<72::aid-pros9>3.0.co;2-u. Prostate. 2000. PMID: 10960845
-
Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer.Prostate. 2000 Nov 1;45(3):216-24. doi: 10.1002/1097-0045(20001101)45:3<216::aid-pros3>3.0.co;2-c. Prostate. 2000. PMID: 11074523
-
Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials.Urology. 2001 Apr;57(4 Suppl 1):143-7. doi: 10.1016/s0090-4295(00)00961-4. Urology. 2001. PMID: 11295614 Review.
-
Role of angiogenesis in the progression and treatment of prostate cancer.Cancer Invest. 2001;19(2):181-91. doi: 10.1081/cnv-100000152. Cancer Invest. 2001. PMID: 11296622 Review. No abstract available.
Cited by
-
The role of CXC chemokines and their receptors in the progression and treatment of tumors.J Mol Histol. 2012 Dec;43(6):699-713. doi: 10.1007/s10735-012-9435-x. Epub 2012 Jun 30. J Mol Histol. 2012. PMID: 22752457 Review.
-
Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions.Clin Cancer Res. 2014 Feb 1;20(3):617-30. doi: 10.1158/1078-0432.CCR-13-0839. Epub 2013 Oct 4. Clin Cancer Res. 2014. PMID: 24097861 Free PMC article.
-
The role of extracellular vesicles and interleukin-8 in regulating and mediating neutrophil-dependent cancer drug resistance.Front Oncol. 2022 Dec 16;12:947183. doi: 10.3389/fonc.2022.947183. eCollection 2022. Front Oncol. 2022. PMID: 36591453 Free PMC article. Review.
-
Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.Int J Cancer. 2007 Sep 1;121(5):999-1008. doi: 10.1002/ijc.22802. Int J Cancer. 2007. PMID: 17487836 Free PMC article.
-
Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells.Am J Pathol. 1999 May;154(5):1503-12. doi: 10.1016/S0002-9440(10)65404-1. Am J Pathol. 1999. PMID: 10329603 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical